| The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer HA Yasar, K Bir Yucel, C Arslan, G Ucar, S Karakaya, B Bilgin, H Taban, ... Journal of Oncology Pharmacy Practice 26 (5), 1110-1116, 2020 | 26 | 2020 |
| Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib A Gökyer, A Küçükarda, O Köstek, MB Hacıoğlu, BS Sunal, NC Demircan, ... Clinical and Translational Oncology 21, 1518-1523, 2019 | 23 | 2019 |
| Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma A Küçükarda, B Erdoğan, A Gökyer, S Sayın, İ Gökmen, E Özcan, ... Supportive Care in Cancer, 1-9, 2022 | 19 | 2022 |
| The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and … E Yekedüz, D Tural, İ Ertürk, S Karakaya, C Erol, Ö Ercelep, Ç Arslan, ... Journal of Cancer Research and Clinical Oncology 148 (12), 3537-3546, 2022 | 12 | 2022 |
| Iatrogenic Cushing's syndrome after topical steroid therapy for psoriasis B Sahıp, M Celık, S Ayturk, A Kucukarda, O Mert, N Dıncer, S Guldıken, ... Indian Journal of Dermatology 61 (1), 120, 2016 | 12 | 2016 |
| Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102 MB Hacıoğlu, O Köstek, N Kurt, A Küçükarda, A Gökyer, FE Ustabaşıoğlu, ... Journal of BU ON., 2019 | 10 | 2019 |
| Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study) M Hizal, MAN Sendur, HA Yasar, K Bir Yucel, C Arslan, G Ucar, ... Journal of Oncology Pharmacy Practice 26 (7), 1583-1589, 2020 | 9 | 2020 |
| The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors KB Yücel, E Yekedüz, S Karakaya, D Tural, İ Ertürk, C Erol, Ö Ercelep, ... Scientific reports 12 (1), 16559, 2022 | 8 | 2022 |
| Benign and malignant thyroid gland diseases in the patients with primary hyperparathyroidism M Celik, S Guldiken, S Ayturk, BY Bulbul, E Tastekin, N Can, A Sezer, ... International Journal of Applied and Basic Medical Research 7 (2), 117-120, 2017 | 7 | 2017 |
| Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated … A Küçükarda, A Gökyer, I Gökmen, E Özcan, MB Hacıoğlu, B Erdoğan, ... Actas Urológicas Españolas (English Edition) 46 (5), 301-309, 2022 | 6 | 2022 |
| Secondary pneumothorax during immunotherapy in two patients with metastatic solid tumors; a new entity A Kucukarda, S Sayın, A Gokyer, MB Aykan, N Karadurmuş, İ Cicin Immunotherapy 13 (7), 565-570, 2021 | 6 | 2021 |
| Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer O Köstek, NC Demircan, A Gökyer, A Küçükarda, BS Sunal, MB Hacıoğlu, ... Clinical and Translational Oncology 21, 1510-1517, 2019 | 5 | 2019 |
| The albumin-bilirubin (ALBI) grade as a significant prognostic factor in colorectal cancer patients with liver metastases N Demircan, O Köstek, A Gökyer, A Küçükarda, M Hacıoğlu, B Erdoğan, ... Journal of Surgery and Medicine 3 (12), 841-844, 2019 | 4 | 2019 |
| Patient with type 1 distal renal tubular acidosis secondary to Sjogren’s syndrome presented with hypokalemic paralysis M Celik, S Ayturk, O Mert, A Kucukarda, I Kurultak, S Donmez, S Guldiken, ... Journal of Medical Cases 6 (6), 268-270, 2015 | 4 | 2015 |
| Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group C Erol, MAN Sendur, I Bilgetekin, DB Garbioglu, J Hamdard, S Akbas, ... Journal of cancer research and therapeutics 18 (Suppl 2), S347-S353, 2022 | 3 | 2022 |
| Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study A Gökyer, A Küçükarda, O Köstek, MB Hacıoğlu, S Uzunoğlu, O Kula, ... International Journal of Clinical Oncology 25, 1757-1762, 2020 | 3 | 2020 |
| External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium … E Yekedüz, S Karakaya, İ Ertürk, D Tural, G Uçar, NŞ Öztaş, R Arıkan, ... Clinical Genitourinary Cancer 21 (1), 175-182, 2023 | 2 | 2023 |
| The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study I Dogan, M Ayhan, M Gurbuz, A Kucukarda, E Aydin, Y Urun, I Cicin, ... Medicine 101 (35), e30147, 2022 | 2 | 2022 |
| Recurrent delayed immune-related pneumonitis after immune-checkpoint inhibitor therapy for advanced osteosarcoma A Küçükarda, İ Gökmen, E Özcan, P Peker, F Akgül, İ Çiçin Immunotherapy 14 (6), 395-399, 2022 | 2 | 2022 |
| Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma A Gökyer, A Küçükarda, O Köstek, İ Gökmen, E Özcan, S Sayın, ... Tumori Journal 108 (2), 141-146, 2022 | 2 | 2022 |
Irfan Cicin (ORCID ID: 0000-0002-758...Istinye University, TurkeyVerified email at istinye.edu.tr
